Special Issue "Advances in Restorative Neurotherapeutic Technologies"

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neurotechnology and Neuroimaging".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1855

Special Issue Editors

Department of Neurosurgery, Stanford University, Stanford, CA 94305, USA
Interests: neuromodulation; deep brain stimulation; cognitive prosthetics; brain computer interface
Department of Neurosurgery, Stanford University, Stanford, CA 94305, USA
Interests: psychiatric neuromodulation; consciousness; deep brain stimulation; intracranial electrophysiology

Special Issue Information

Dear Colleagues,

From Ramon y Cajal and Golgi’s histological techniques to single-cell RNA sequencing, technological innovations have long driven progress in the neurosciences. We are entering an era in which new technologies have the power not only to help us understand the inner workings of the brain or to treat the symptoms of the diseases that plague it but also to restore function to those affected by disorders of the central nervous system. From individualized network-based neuromodulatory therapies for neurologic and psychiatric disease, to brain–computer interfaces to restore movement in quadriplegics and to restore vision for the blind, cognitive prosthetics for dementia and learning disabilities, seizure-detecting responsive neurostimulators, augmented reality headsets to help neurosurgeons locate brain tumors and wearable electric field-generating devices to help limit their growth, and many more—today’s rich technological landscape is changing the way we think about maintaining and increasing neurological well-being.

This Special Issue explores some of the technologies that have allowed interdisciplinary teams of neurosurgeons, neurologists, and psychiatrists to revolutionize the approach to treatment-refractory neurologic and psychiatric disease. We examine the latest applications of these techniques, including the potential not only to restore but to augment nervous system function and improve the quality of life for patients who have exhausted traditional therapies.

Dr. Vivek P. Buch
Dr. David Arnold Purger
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuro regeneration
  • neuro restoration
  • implantable devices
  • neuromodulation
  • circuit therapeutics
  • stem cell
  • gene therapy
  • drug delivery
  • molecular brain therapies
  • restorative neurosurgery

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Jump to: Other

14 pages, 280 KiB  
Review
An Insight into the Prospects and Drawbacks of Stem Cell Therapy for Spinal Cord Injuries: Ongoing Trials and Future Directions
Brain Sci. 2023, 13(12), 1697; https://doi.org/10.3390/brainsci13121697 (registering DOI) - 09 Dec 2023
Viewed by 207
Abstract
Spinal cord injury (SCI) is a devastating neurological disorder that has a substantial detrimental impact on a person’s quality of life. The estimated global incidence of SCI is 40 to 80 cases per million people and around 90% of cases are traumatic. Various [...] Read more.
Spinal cord injury (SCI) is a devastating neurological disorder that has a substantial detrimental impact on a person’s quality of life. The estimated global incidence of SCI is 40 to 80 cases per million people and around 90% of cases are traumatic. Various etiologies can be recognized for SCI, and post-traumatic SCI represents the most common of these. Patients worldwide with SCI suffer from a persistent loss of motor and sensory function, which affects every aspect of their personal and social lives. Given the lack of effective treatments, many efforts have been made to seek a cure for this condition. In recent years, thanks to their ability to regenerate tissue and repair lost or damaged cells, much attention has been directed toward the use of stem cells (embryonic, induced pluripotent, mesenchymal, hematopoietic), aimed at restoring the functional integrity of the damaged spinal cord and improving a functional recovery including sensory and motor function. In this paper, we offer an overview of the benefits and drawbacks of stem cell therapy for SCI based on clinical evidence. This report also addresses the characteristics of various stem cell treatments, as well as the field’s likely future. Each cell type targets specific pathological characteristics associated with SCI and demonstrates therapeutic effects via cell replacement, nutritional support, scaffolds, and immunomodulation pathways. SCI accompanied by complex pathological processes cannot be resolved by single treatment measures. Stem cells are associated with the adjustment of the expression of neurotrophic factors that help to achieve better nutrition to damaged tissue. Single-cell treatments have been shown in some studies to provide very minor benefits for SCI in multiple preclinical studies and a growing number of clinical trials. However, SCI damage is complex, and many studies are increasingly recognizing a combination approach such as physical therapy, electrical stimulation, or medication therapy to treatment. Full article
(This article belongs to the Special Issue Advances in Restorative Neurotherapeutic Technologies)
23 pages, 1642 KiB  
Review
Cell Replacement Therapy for Brain Repair: Recent Progress and Remaining Challenges for Treating Parkinson’s Disease and Cortical Injury
Brain Sci. 2023, 13(12), 1654; https://doi.org/10.3390/brainsci13121654 - 29 Nov 2023
Viewed by 696
Abstract
Neural transplantation represents a promising approach to repairing damaged brain circuitry. Cellular grafts have been shown to promote functional recovery through “bystander effects” and other indirect mechanisms. However, extensive brain lesions may require direct neuronal replacement to achieve meaningful restoration of function. While [...] Read more.
Neural transplantation represents a promising approach to repairing damaged brain circuitry. Cellular grafts have been shown to promote functional recovery through “bystander effects” and other indirect mechanisms. However, extensive brain lesions may require direct neuronal replacement to achieve meaningful restoration of function. While fetal cortical grafts have been shown to integrate with the host brain and appear to develop appropriate functional attributes, the significant ethical concerns and limited availability of this tissue severely hamper clinical translation. Induced pluripotent stem cell-derived cells and tissues represent a more readily scalable alternative. Significant progress has recently been made in developing protocols for generating a wide range of neural cell types in vitro. Here, we discuss recent progress in neural transplantation approaches for two conditions with distinct design needs: Parkinson’s disease and cortical injury. We discuss the current status and future application of injections of dopaminergic cells for the treatment of Parkinson’s disease as well as the use of structured grafts such as brain organoids for cortical repair. Full article
(This article belongs to the Special Issue Advances in Restorative Neurotherapeutic Technologies)
Show Figures

Figure 1

Other

Jump to: Review

7 pages, 6154 KiB  
Case Report
Neoadjuvant Chemotherapy with Laser Interstitial Thermal Therapy in Central Nervous System Neuroblastoma: Illustrative Case and Literature Review
Brain Sci. 2023, 13(11), 1515; https://doi.org/10.3390/brainsci13111515 - 26 Oct 2023
Viewed by 589
Abstract
Primitive neuroectodermal tumors of the central nervous system, or CNS neuroblastoma, are rare neoplasms in children. Recently, methylation profiling enabled the discovery of four distinct entities of these tumors. The current treatment paradigm involves surgical resection followed by chemotherapy and radiation. However, upfront [...] Read more.
Primitive neuroectodermal tumors of the central nervous system, or CNS neuroblastoma, are rare neoplasms in children. Recently, methylation profiling enabled the discovery of four distinct entities of these tumors. The current treatment paradigm involves surgical resection followed by chemotherapy and radiation. However, upfront surgical resection carries high surgical morbidity in this patient population due to their young age, tumor vascularity, and often deep location in the brain. We report a case of CNS neuroblastoma that can be successfully treated with neoadjuvant chemotherapy followed by minimally invasive laser interstitial thermal therapy and radiation. The patient has complete treatment with no evidence of recurrence at one year follow-up. This case illustrates a potential paradigm shift in the treatment of these rare tumors can be treated using minimally invasive surgical approach to achieve a favorable outcome. Full article
(This article belongs to the Special Issue Advances in Restorative Neurotherapeutic Technologies)
Show Figures

Figure 1

Back to TopTop